Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on LinkedIn:
“Delighted to have served as an invited faculty speaker + key panel discussant at the lively and engaging inaugural Pan-Hematology Meeting hosted by MD Education in Puerto Rico last week.
I was able to deliver my talk on BPDCN Updates for 2026 and appreciated the opportunity to continue my lifelong quest to raise awareness and improve patient outcomes and increase research for Rare Disease, Rare Blood Cancers !
I truly enjoyed the intellectual discourse and new ideas among my colleagues at this new meeting in our ever-growing Rare Disease, Rare Blood Cancer field!”
Other articles about Blood Cancer on OncoDaily.
